INVA
Innoviva Inc

1,503
Loading...
Loading...
News
all
press releases
Johnson & Johnson (JNJ) Beats Q3 Earnings and Revenue Estimates
Johnson & Johnson (JNJ) delivered earnings and revenue surprises of +1.08% and +1.03%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·6d ago
News Placeholder
More News
News Placeholder
New Strong Buy Stocks for October 10th
EGAN, MDB, INVA, LIF and PGR have been added to the Zacks Rank #1 (Strong Buy) List on October 10th, 2025.
Zacks·10d ago
News Placeholder
Are Investors Undervaluing Innoviva (INVA) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks·13d ago
News Placeholder
Innoviva to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
Innoviva, Inc. (NASDAQ: INVA) (Innoviva or the Company), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva...
Business Wire·9mo ago
News Placeholder
US Futures Jump, Ignore Global Selloff While Focusing On Imminent Rate Cut
US Futures Jump, Ignore Global Selloff While Focusing On Imminent Rate Cut The last full week of 2024 started off with a burst of US exceptionalism which helped US equity futures shrug...
Zero Hedge·10mo ago
News Placeholder
Innoviva Specialty Therapeutics Signs Exclusive Distribution and Licensing Agreement to Acquire U.S. Marketing Rights for Zevtera (ceftobiprole)
Innoviva Specialty Therapeutics, Inc., (IST) a subsidiary of Innoviva, Inc. (Nasdaq: INVA), today announced it has entered into an exclusive distribution and license agreement with Basilea...
Business Wire·10mo ago
News Placeholder
Innoviva to Participate in the Citi 2024 Global Healthcare Conference
Innoviva, Inc. (NASDAQ: INVA) (Innoviva or the Company), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva...
Business Wire·11mo ago
News Placeholder
Innoviva to Participate in the UBS Global Healthcare Conference
Innoviva, Inc. (NASDAQ: INVA) (Innoviva or the Company), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva...
Business Wire·11mo ago
News Placeholder
Innoviva Reports Third Quarter 2024 Financial Results; Highlights Recent Company Progress
Innoviva, Inc. (NASDAQ: INVA) (Innoviva or the Company), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva...
Business Wire·1y ago
News Placeholder
Innoviva to Participate in Upcoming Investor Conferences
Innoviva, Inc. (NASDAQ: INVA) (Innoviva or the Company), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva...
Business Wire·1y ago

Latest INVA News

View

Advertisement|Remove ads.

Advertisement|Remove ads.